These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14767337)

  • 1. A porcine model of calcium oxalate kidney stone disease.
    Mandel NS; Henderson JD; Hung LY; Wille DF; Wiessner JH
    J Urol; 2004 Mar; 171(3):1301-3. PubMed ID: 14767337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary oxalate and calcium oxalate nephrolithiasis.
    Khan SR; Glenton PA; Byer KJ
    J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
    Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic evidence of calculus attachment to Randall's plaque.
    Matlaga BR; Williams JC; Kim SC; Kuo RL; Evan AP; Bledsoe SB; Coe FL; Worcester EM; Munch LC; Lingeman JE
    J Urol; 2006 May; 175(5):1720-4; discussion 1724. PubMed ID: 16600740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual morphology of calcium oxalate calculi in primary hyperoxaluria.
    Daudon M; Estepa L; Lacour B; Jungers P
    J Nephrol; 1998; 11 Suppl 1():51-5. PubMed ID: 9604812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies using a porcine model: what insights into human calcium oxalate stone formation mechanisms has this model facilitated?
    Penniston KL; Patel SR; Schwahn DJ; Nakada SY
    Urolithiasis; 2017 Feb; 45(1):109-125. PubMed ID: 27904915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation.
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; van 't Noordende JM; Schrder FH
    Scanning Microsc; 1995 Mar; 9(1):115-24; discussion 124-5. PubMed ID: 8553010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counteraction of oxalate induced nitrosative stress by supplementation of l-arginine, a potent antilithic agent.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Apr; 354(1-2):159-66. PubMed ID: 15748613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
    Moriyama MT; Glenton PA; Khan SR
    J Urol; 2001 May; 165(5):1687-92. PubMed ID: 11342956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats.
    Nakatani T; Ishii K; Yoneda Y; Kamikawa S; Kanazawa T; Sugimoto T; Osswald H
    Urol Res; 2002 Oct; 30(5):329-35. PubMed ID: 12389123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model.
    Kaplon DM; Penniston KL; Darriet C; Crenshaw TD; Nakada SY
    J Endourol; 2010 Mar; 24(3):355-9. PubMed ID: 20078233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
    Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
    J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.